Which Banks Capture the $197B IPO Wave: Goldman and Morgan Stanley or the Diversified Giants?
Blackstone's Q1 beat and 'best year ever' IPO forecast spotlight a revenue gap the Street hasn't priced—pure-play underwriters trade at parity with diversified banks despite 3-5x the fee exposure
Key Takeaways
Blackstone's April 22 earnings beat and President Jon Gray's prediction of the firm's "best year ever" for stock listings confirm the $197B mega-IPO pipeline is moving from announced to executable, with 12 Blackstone portfolio companies in the queue. Goldman Sachs and Morgan Stanley derive 18-22% of revenue from investment banking versus JPMorgan's 7%, yet all three trade at 12-13x forward earnings—the market hasn't differentiated underwriting exposure despite a 210% spike in global IPO coverage over 30 days and reports of 40% higher pipeline bookings at top banks in H1 2024. Long GS and MS versus JPM over six months targets 8-12% relative outperformance as Q2 and Q3 underwriting revenue prints surface the fee differential, with Coinbase as a parallel play on crypto IPO infrastructure revenue. The thesis breaks if fewer than $50B of the pipeline prices by September 30, 2026, or if GS and MS Q2 investment banking revenue shows no sequential growth from Q1 2026.
Blackstone's April 22 distributable earnings beat—$1.34 per share versus consensus $1.18—came with Jon Gray's declaration that 2026 would be the private equity giant's "best year ever" for portfolio company IPOs. The firm has 12 companies in the announced $197B pipeline, and Gray's confidence reflects what capital markets desks have been building toward since January: the first sustained IPO window since 2021. GDELT news data shows IPO-related coverage spiked 210% over the past 30 days, and top investment banks reported 40% higher pipeline bookings in the first half of 2024. The question is which public equities capture the fee revenue—and the market is pricing the answer wrong.
The Consensus Frame: IPO Recovery as Broad Financial Sector Tailwind
Goldman Sachs trades at 12.8x forward earnings, Morgan Stanley at 12.4x, and JPMorgan at 12.9x. The multiples suggest the Street views IPO recovery as a rising tide lifting all boats—diversified banks with retail deposit franchises and pure-play underwriters get the same credit. Revenue mix tells a different story. Goldman Sachs derived 22% of 2023 revenue from investment banking, Morgan Stanley 18%, and JPMorgan 7%. On a $197B pipeline, assuming a blended 3.5% underwriting fee (tech and crypto IPOs run higher than the 2-3% industrial average), the aggregate fee pool is $6.9B. Goldman and Morgan Stanley historically capture 35-40% combined market share of large-cap tech and financial IPOs; JPMorgan's share runs 12-15%. The incremental revenue for GS and MS scales to 4-5% of 2025 investment banking revenue if half the pipeline prices in 2026. For JPMorgan, the same math yields 1.2%.
The Structural Asymmetry: Underwriting Concentration in a Narrow Cohort
The $197B pipeline skews heavily toward technology and crypto—sectors where Goldman Sachs and Morgan Stanley have entrenched lead-left relationships and JPMorgan plays a supporting role. Coinbase, which reported Q1 2024 transaction revenue of $935M (up 150% year-over-year), sits at the center of the crypto IPO infrastructure layer: firms going public need exchange listings, institutional custody, and on-chain analytics, all of which Coinbase monetizes. The company's April 2026 YTD return of +18.3% reflects some of this, but consensus 2026 revenue models carry $4.1B, implying no material uplift from crypto IPO-related activity despite the filing rate hitting the highest level since 2021. Robinhood, with 23% market share in retail IPO allocations, trades at 15.2x forward earnings—a 20% premium to the diversified banks—but the absolute dollar revenue from IPO access fees is small relative to its $2.1B revenue base. The real operating leverage sits with the underwriters and Coinbase.
Why the Tape Misread It: Behavioral Anchoring to 2021-2023 Drought
Investors spent 2022-2023 watching IPO markets freeze—zero billion-dollar tech IPOs priced in 2023, and investment banking revenue at Goldman Sachs fell 28% from 2021 to 2023. The behavioral anchor is the drought, not the 2020-2021 boom. When Blackstone's Gray made his "best year ever" comment on April 22, Goldman Sachs stock moved +1.2% intraday and closed flat; Morgan Stanley +0.8%. The market heard the signal but didn't reprice the multiple. JPMorgan, by contrast, trades on net interest income expectations and credit quality—its investment banking revenue is a rounding error in the equity story. The mispricing is that GS and MS carry the same 12-13x forward multiple as JPM despite 3-5x the revenue sensitivity to the IPO cycle.
The Trade: Long GS and MS, Pair with JPM, Add COIN
Long Goldman Sachs and Morgan Stanley versus JPMorgan over six months, sized as a 2:1 ratio (two units GS/MS, one unit short JPM), targets 8-12% relative outperformance. The catalyst path: Q2 2026 earnings (mid-July) will show the first sequential uptick in investment banking revenue as April and May IPO pricings hit the books, and Q3 (mid-October) will capture the summer wave. Coinbase as a standalone long benefits from the same pipeline—crypto firms filing at 2021 rates need exchange infrastructure, and COIN's transaction revenue scales directly with listing activity and post-IPO trading volume. Size COIN at 50% of the GS/MS position; it carries higher beta but the revenue sensitivity is comparable. Robinhood is a pass—the retail IPO access story is already in the 15x multiple, and the absolute dollar upside is subscale.
What Breaks the Thesis
The call invalidates if fewer than $50B of the $197B pipeline prices by September 30, 2026—that would indicate the window closed before the bulk of deals executed, and underwriting revenue would revert to 2023-2024 run rates. It also breaks if Goldman Sachs and Morgan Stanley report Q2 2026 investment banking revenue flat or down sequentially from Q1 2026, which would mean the pipeline bookings didn't convert to closed deals. Finally, if GS and MS underperform JPM by more than 5% over the six-month window, the thesis is wrong—either the fee pool didn't materialize or the market priced it in faster than the revenue data supported. The Blackstone signal and the 210% coverage spike say the window is open; the next 120 days will show whether it stays open long enough to reprice the underwriters.